Circassia Group Plc

OTCGREY:CSSPF USA Medical Devices
Market Cap
$313.45 Million
Market Cap Rank
#13963 Global
#5695 in USA
Share Price
$0.75
Change (1 day)
+0.00%
52-Week Range
$0.75 - $0.75
All Time High
$3.77
About

NIOX Group Plc engages in the design, development, and commercialization of medical devices for asthma diagnosis, monitoring, and management worldwide. It offers NIOX VERO, a non-invasive and point-of-care system that comprises a small portable device and a range of consumables, including sensors, individual disposable mouthpieces, and breathing handles for the measurement of Fractional Exhaled N… Read more

Circassia Group Plc - Asset Resilience Ratio

Latest as of December 2018: 0.00%

Circassia Group Plc (CSSPF) has an Asset Resilience Ratio of 0.00% as of December 2018. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets
$0.00
Cash + Short-term Investments
Total Assets
$307.40 Million
All company assets
Resilience Assessment
Low
Financial Resilience Level

Asset Resilience Ratio Trend (2013–2018)

This chart shows how Circassia Group Plc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.

Liquid Assets Composition Over Time

This chart breaks down Circassia Group Plc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents $0.00 0%
Short-term Investments $0.00 0%
Total Liquid Assets $0.00 0.00%

Asset Resilience Insights

  • Limited Liquidity: Circassia Group Plc maintains only 0.00% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company maintains a balanced mix of cash and short-term investments.

Circassia Group Plc Industry Peers by Asset Resilience Ratio

Compare Circassia Group Plc's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022
Medical Devices 0.01%
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223
Medical Devices 0.26%
Double Medical Technology Inc
SHE:002901
Medical Devices 7.79%
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932
Medical Devices 6.64%
Shinhung
KO:004080
Medical Devices 4.17%
UMediC Group Berhad
KLSE:0256
Medical Devices 1.48%
Osang Healthcare Co.,Ltd
KQ:036220
Medical Devices 9.34%
HansBiomed Corporation
KQ:042520
Medical Devices 9.13%

Annual Asset Resilience Ratio for Circassia Group Plc (2013–2018)

The table below shows the annual Asset Resilience Ratio data for Circassia Group Plc.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2018-12-31 0.00% $0.00 $307.40 Million --
2017-12-31 3.73% $15.00 Million $402.40 Million -2.26pp
2016-12-31 5.99% $20.00 Million $334.10 Million -1.74pp
2015-12-31 7.73% $37.80 Million $489.20 Million -70.53pp
2014-12-31 78.25% $156.90 Million $200.50 Million +59.73pp
2013-12-31 18.53% $7.05 Million $38.03 Million --
pp = percentage points